Statistics
Publications
1
Citations
58
H-Index
1
Active since
2020
Affiliations
Hebei Medical University(Current)
Lingrui Su is an author at Hebei Medical University specializing in oncogenic signaling pathways, oncology, and checkpoint inhibitor therapy.
Publications per year
2020–2020
1
1
EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma
Lingrui Su, Wenli Guo, Lei Lou et al. · Molecular Carcinogenesis · 2020 · 58 citations
Medicine, Cancer Biology, Oncology +17
1–1 of 1